interstitial lung disease

LATE-BREAKING ABSTRACT: Role of trans-bronchial lung cryobiopsies in interstitial lung diseases: Preliminary results of a Belgian prospective study
Benjamin Bondue, Thierry Pieters, Patrick Alexander, Paul De Vuyst, Delphine Hoton, Myriam Remmelink, Dimitri Leduc

European Respiratory Journal Sep 2016, 48 (suppl 60) OA4567; DOI: 10.1183/13993003.congress-2016.OA4567
Analyses of the relationship between ΔFVC, extent of fibrosis and extent of emphysema in patients with idiopathic pulmonary fibrosis (IPF)
Vincent Cottin, David M. Hansell, Nicola Sverzellati, Derek Weycker, Katerina M. Antoniou, Mark Atwood, Gerry Oster, Klaus-Uwe Kirchgaessler, Athol U. Wells

European Respiratory Journal Sep 2016, 48 (suppl 60) OA4568; DOI: 10.1183/13993003.congress-2016.OA4568
Strong reversal of the lung fibrosis disease signature by autotaxin inhibitor GLPG1690 in a mouse model for IPF
Maté Ongenaert, Sonia Dupont, Roland Blanqué, Reginald Brys, Ellen van der Aar, Bertrand Heckmann

European Respiratory Journal Sep 2016, 48 (suppl 60) OA4540; DOI: 10.1183/13993003.congress-2016.OA4540
Transbronchial pulmonary criobiopsy's relevance in the diagnostic approach of diffuse pulmonary diseases- Data analysis of the initial learning curve
Leonor Almeida, Patrícia Mota, Natália Melo, José Miguel Pereira, Rui Cunha, Susana Guimarães, Conceição Souto-Moura, Adriana Magalhães, António Morais

European Respiratory Journal Sep 2016, 48 (suppl 60) OA4574; DOI: 10.1183/13993003.congress-2016.OA4574
A case series of eight patients treated with alectinib including a case of interstitial lung disease
Yoshihiko Sakata, Kodai Kawamura, Yuko Yasuda, Naoki Shingu, Keisuke Anan, Kazuya Ichikado

European Respiratory Journal Sep 2016, 48 (suppl 60) OA3343; DOI: 10.1183/13993003.congress-2016.OA3343
LATE-BREAKING ABSTRACT: DS102: A bioactive lipid for the treatment of chronic pulmonary disorders
Robert Lumsden, David Coughlan, John Climax

European Respiratory Journal Sep 2016, 48 (suppl 60) OA3537; DOI: 10.1183/13993003.congress-2016.OA3537
Negative outcome of prednisone in possible idiopathic pulmonary fibrosis
Ivo Wiertz, Wim Wuyts, Coline van Moorsel, Renske Vorselaars, Miranda Ten Hoedt-Zijp, Wouter van Es, Matthijs van Oosterhout, Jan Grutters

European Respiratory Journal Sep 2016, 48 (suppl 60) OA4571; DOI: 10.1183/13993003.congress-2016.OA4571
Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry
Michael Kreuter, Hubert Wirtz, Antje Prasse, David Pittrow, Dirk Koschel, Jens Klotsche, Stefan Andreas, Martin Claussen, Christian Grohé, Matthias Held, Sven Gläser, Heinrike Wilkens, F. Joachim Meyer, Martin Schwaiblmair, Dirk Skowasch, Joachim Kirschner, Andrea Koch, Claus Neurohr, Rudolf M. Huber, Winfried J. Randerath, Ralf Ewert, Juergen Behr

European Respiratory Journal Sep 2016, 48 (suppl 60) OA4570; DOI: 10.1183/13993003.congress-2016.OA4570
Twenty-four week decline in forced vital capacity predicts mortality at week 52 in the INPULSIS® trials
Luca Richeldi, Arata Azuma, Moisés Selman, Wenbo Tang, Jorge Capapey, Susanne Stowasser, Vincent Cottin

European Respiratory Journal Sep 2016, 48 (suppl 60) OA1814; DOI: 10.1183/13993003.congress-2016.OA1814
Transbronchial Cryobiopsy – Is the bleeding risk changed in comparison to transbronchial forceps biopsy?
Juergen Hetzel, Christoph Petermann, Ralf Eberhardt, Wolfgang Gesierich, Kaid Darwiche, Lars Hagmayer, Ahmed Ehab, Michael Boeckeler, Maik Haentschel

European Respiratory Journal Sep 2016, 48 (suppl 60) OA3018; DOI: 10.1183/13993003.congress-2016.OA3018

Main menu

User menu

Search

interstitial lung disease

Pages

Contact us